Aurora Cannabis Inc. (ACB.TO)
CAD 6.15
(4.24%)
CAD 6.15
(4.24%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -46.45 Million CAD | 81.08% |
| 2022 | -245.49 Million CAD | -6.07% |
| 2021 | -231.44 Million CAD | 18.16% |
| 2020 | -282.81 Million CAD | 42.4% |
| 2019 | -490.96 Million CAD | -56.24% |
| 2018 | -314.24 Million CAD | -228.12% |
| 2017 | -95.77 Million CAD | -755.72% |
| 2016 | -11.19 Million CAD | -143.8% |
| 2015 | -4.59 Million CAD | -5.12% |
| 2014 | -4.36 Million CAD | -1324.92% |
| 2013 | -306.48 Thousand CAD | 23.93% |
| 2012 | -402.87 Thousand CAD | -21.79% |
| 2011 | -330.78 Thousand CAD | -63.69% |
| 2010 | -202.07 Thousand CAD | -246.91% |
| 2009 | -58.25 Thousand CAD | 59.92% |
| 2008 | -145.34 Thousand CAD | 36.54% |
| 2007 | -229.04 Thousand CAD | -18282.58% |
| 2006 | -1246.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | 3.15 Million CAD | 113.19% |
| 2023 Q1 | -11.04 Million CAD | 31.44% |
| 2023 FY | -46.45 Million CAD | 81.08% |
| 2023 Q2 | -23.89 Million CAD | -116.26% |
| 2022 FY | -245.49 Million CAD | -6.07% |
| 2022 Q4 | -16.11 Million CAD | 0.76% |
| 2022 Q2 | -71.59 Million CAD | -33.02% |
| 2022 Q1 | -53.82 Million CAD | 15.77% |
| 2022 Q3 | -16.23 Million CAD | 77.32% |
| 2021 Q4 | -63.9 Million CAD | 11.72% |
| 2021 Q3 | -72.38 Million CAD | -29.73% |
| 2021 Q1 | -39.37 Million CAD | 22.01% |
| 2021 Q2 | -55.79 Million CAD | -41.7% |
| 2021 FY | -231.44 Million CAD | 18.16% |
| 2020 Q1 | -42.32 Million CAD | 79.88% |
| 2020 Q2 | -47.04 Million CAD | -11.16% |
| 2020 Q3 | -142.95 Million CAD | -203.85% |
| 2020 Q4 | -50.48 Million CAD | 64.68% |
| 2020 FY | -282.81 Million CAD | 42.4% |
| 2019 FY | -490.96 Million CAD | -56.24% |
| 2019 Q4 | -210.38 Million CAD | -151.75% |
| 2019 Q3 | -83.56 Million CAD | 30.13% |
| 2019 Q2 | -119.61 Million CAD | -54.53% |
| 2019 Q1 | -77.4 Million CAD | -73.69% |
| 2018 Q4 | -44.56 Million CAD | 42.58% |
| 2018 FY | -314.24 Million CAD | -228.12% |
| 2018 Q3 | -77.61 Million CAD | 3.21% |
| 2018 Q2 | -80.19 Million CAD | 28.32% |
| 2018 Q1 | -111.87 Million CAD | -140.66% |
| 2017 FY | -95.77 Million CAD | -755.72% |
| 2017 Q4 | -46.48 Million CAD | -46.38% |
| 2017 Q3 | -31.75 Million CAD | -97.07% |
| 2017 Q2 | -16.11 Million CAD | -1036.39% |
| 2017 Q1 | -1.41 Million CAD | 61.76% |
| 2016 Q1 | -3.27 Million CAD | -34.7% |
| 2016 Q2 | -2.37 Million CAD | 27.44% |
| 2016 Q3 | -1.83 Million CAD | 22.86% |
| 2016 Q4 | -3.7 Million CAD | -102.28% |
| 2016 FY | -11.19 Million CAD | -143.8% |
| 2015 Q1 | -1.18 Million CAD | 43.62% |
| 2015 Q3 | -2.66 Million CAD | -496.14% |
| 2015 Q2 | 673.59 Thousand CAD | 156.97% |
| 2015 Q4 | -2.43 Million CAD | 8.89% |
| 2015 FY | -4.59 Million CAD | -5.12% |
| 2014 Q2 | -1.18 Million CAD | -118.47% |
| 2014 Q4 | -2.09 Million CAD | -404.16% |
| 2014 Q3 | 689.46 Thousand CAD | 158.15% |
| 2014 Q1 | -542.73 Thousand CAD | -288.14% |
| 2014 FY | -4.36 Million CAD | -1324.92% |
| 2013 FY | -306.48 Thousand CAD | 23.93% |
| 2013 Q2 | -30.77 Thousand CAD | 25.56% |
| 2013 Q3 | -94.54 Thousand CAD | -207.19% |
| 2013 Q4 | -139.82 Thousand CAD | -47.9% |
| 2013 Q1 | -41.34 Thousand CAD | 61.45% |
| 2012 Q1 | -151.76 Thousand CAD | 24.9% |
| 2012 Q3 | -75.2 Thousand CAD | -6.71% |
| 2012 FY | -402.87 Thousand CAD | -21.79% |
| 2012 Q2 | -70.47 Thousand CAD | 53.56% |
| 2012 Q4 | -107.24 Thousand CAD | -42.6% |
| 2011 Q1 | -44.52 Thousand CAD | 24.02% |
| 2011 Q4 | -202.08 Thousand CAD | -346.0% |
| 2011 FY | -330.78 Thousand CAD | -63.69% |
| 2011 Q2 | -38.86 Thousand CAD | 12.71% |
| 2011 Q3 | -45.31 Thousand CAD | -16.59% |
| 2010 Q4 | -58.6 Thousand CAD | -1.93% |
| 2010 Q1 | -37.91 Thousand CAD | 24.11% |
| 2010 Q2 | -48.07 Thousand CAD | -26.81% |
| 2010 FY | -202.07 Thousand CAD | -246.91% |
| 2010 Q3 | -57.48 Thousand CAD | -19.57% |
| 2009 FY | -58.25 Thousand CAD | 59.92% |
| 2009 Q4 | -49.95 Thousand CAD | -76.16% |
| 2009 Q3 | -28.35 Thousand CAD | -113.23% |
| 2009 Q2 | -13.3 Thousand CAD | 46.71% |
| 2009 Q1 | -24.95 Thousand CAD | -254.93% |
| 2008 Q4 | 16.1 Thousand CAD | 143.8% |
| 2008 Q2 | -32.47 Thousand CAD | 64.84% |
| 2008 FY | -145.34 Thousand CAD | 36.54% |
| 2008 Q3 | -36.77 Thousand CAD | -13.23% |
| 2008 Q1 | -92.36 Thousand CAD | -128.63% |
| 2007 Q3 | -22.26 Thousand CAD | 86.5% |
| 2007 Q1 | -1425.00 CAD | 0.0% |
| 2007 Q4 | -40.39 Thousand CAD | -81.46% |
| 2007 Q2 | -164.96 Thousand CAD | -11476.14% |
| 2007 FY | -229.04 Thousand CAD | -18282.58% |
| 2006 FY | -1246.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Avicanna Inc. | -7.93 Million CAD | -485.566% |
| Avant Brands Inc. | -1.45 Million CAD | -3101.447% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | -55.958% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | -2274.898% |
| Knight Therapeutics Inc. | -2.89 Million CAD | -1507.37% |
| MediPharm Labs Corp. | -18.25 Million CAD | -154.509% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 80.863% |
| Canopy Growth Corporation | -228.71 Million CAD | 79.689% |
| Willow Biosciences Inc. | -13.18 Million CAD | -252.397% |
| Auxly Cannabis Group Inc. | -19 Million CAD | -144.425% |